Preventive pharmacotherapy of headache disorders /
| Other Authors: | , , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Oxford ; New York :
Oxford University Press,
2004.
|
| Series: | Oxford medical publications.
Frontiers in headache research ; v. 12. |
| Subjects: |
Table of Contents:
- Methodology of prophylactic trials
- Principles of preventive pharmacotherapy in primary headache
- Methodology and implementation of systematic reviews
- Adverse events, equally important as efficacy as an outcome parameter?
- The methodology of prophylactic trials : discussion summary
- Prophylactic drugs I
- Key issues in the methodology of prophylactic migraine trials
- Migraine prophylaxis : a pharmacoepidemiological study of practices used by general practitioners and neurologists in France
- Preventive treatment of migraine headache with rofecoxib
- Prophylactic treatment and course of the disease in headache associated with sexual activity
- Prophylactic drugs I : discussion summary
- Prophylactic drugs II
- Prevention of migraine : beta-blockers and amine agonists : efficacy
- AEDs in migraine prevention
- Mechanism(s) of action of the antiepileptic drugs valproic acid, gabapentin, and topiramate : implications for the prophylactic management of migraine
- Experience with topiramate in patients with refractory migraine
- Topiramate in a selective group of therapy refractory headache patients
- Prophylactic drugs II : discussion summary
- Prophylactic drugs III
- Efficacy of antidepressants in heachache prophylaxis
- Antidepressants : mechanisms of action
- Other prophylactic anti-migraine agents : riboflavin, feverfew, magnesium, botulinum toxin, and calcium antagonists
- Treatment of chronic tension-type headache with mirtazapine
- Botulinum toxin type A in the treatment of refractory headache
- Botulinum toxin A in the prophylaxis of migraine - a double-blind , placebo-controlled, randomized study comparing frontal and cervical injection
- Mechanisms of the antinociceptive effect of subcutaneous BOTOX® : inhibition of peripheral and central nociceptive processing
- Survey of expenditure for analgesics in chronic tension headache and its changes following botulinum toxin type A preventive treatment
- Prophylactic treatment of migraine with lomerizine hydrochloride
- Prophylactic drugs III : discussion summary
- Antagonizing peripheral sensitization in migraine
- New possibilities for antimigraine therapy via 5-HT receptors?
- Dihydroergotamine interaction with 5-HT₂ receptors and its relevance to migraine
- Migraine prophlaxis with drugs influencing the angiotension system
- Naratriptan in the preventive treatment of refractory chronic migraine
- PROMISE study (PROphylaxis of MIgraine with SEglor®)
- Serotonin receptors and migraine prophylaxis - the case of dihydroergotamine
- What is the mechanism of action of ACE inhibitors in migraine prophylaxis?
- Triptans with methysergide
- New targets I : discussion summary
- Nitric oxide and its signalling pathways : a rich source of potential targets for migrain therapy
- Clacitonin gene-related peptide and migriane
- Phosphodiesterases, cyclic nucleotides, and their role in the migraine
- The prostoglandin-E₁-analog misoprostol in the prophylactic treatment of refractory cluster headache and trigeminal neuralgia
- New tagets II : discussion summary